Price (delayed)
$126.84
Market cap
$15.44B
P/E Ratio
60.98
Dividend/share
$0.28
EPS
$2.08
Enterprise value
$17.52B
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.